Journal
JOURNAL OF THE AMERICAN HEART ASSOCIATION
Volume 5, Issue 12, Pages -Publisher
WILEY
DOI: 10.1161/JAHA.116.004248
Keywords
amiloride; blood pressure; cardiovascular diseases; chlorthalidone; clinical trials; diuretics; hypertension; left ventricular mass; microalbuminuria; potassium-sparing antihypertensive agents; prehypertension; prevention
Categories
Funding
- Ministry of Health, Division of Science and Technology (DECIT)
- Ministry of Science and Technology, Brazilian Innovation Agency (FINEP) [01080606/01]
- National Counsel of Technological and Scientific Development (CNPq), Brazil
- National Institute of Health Technology Assessment (IATS)
- Hospital de Clinicas de Porto Alegre (FIPE-GPPG), RS, Brazil [08621]
Ask authors/readers for more resources
Background-Prehypertension is associated with higher cardiovascular risk, target organ damage, and incidence of hypertension. The Prevention of Hypertension in Patients with PreHypertension (PREVER-Prevention) trial aimed to evaluate the efficacy and safety of a low-dose diuretic for the prevention of hypertension and end-organ damage. Methods and Results-This randomized, parallel, double-blind, placebo-controlled trial was conducted in 21 Brazilian academic medical centers. Participants with prehypertension who were aged 30 to 70 years and who did not reach optimal blood pressure after 3 months of lifestyle intervention were randomized to a chlorthalidone/amiloride combination pill or placebo and were evaluated every 3 months during 18 months of treatment. The primary outcome was incidence of hypertension. Development or worsening of microalbuminuria, new-onset diabetes mellitus, and reduction of left ventricular mass were secondary outcomes. Participant characteristics were evenly distributed by trial arms. The incidence of hypertension was significantly lower in 372 study participants allocated to diuretics compared with 358 allocated to placebo (hazard ratio 0.56, 95% CI 0.38-0.82), resulting in a cumulative incidence of 11.7% in the diuretic arm versus 19.5% in the placebo arm(P=0.004). Adverse events; levels of blood glucose, glycosylated hemoglobin, creatinine, and microalbuminuria; and incidence of diabetes mellitus were no different between the 2 arms. Left ventricular mass assessed through Sokolow-Lyon voltage and voltage-duration product decreased to a greater extent in participants allocated to diuretic therapy compared with placebo (P=0.02). Conclusions-A combination of low-dose chlorthalidone and amiloride effectively reduces the risk of incident hypertension and beneficially affects left ventricular mass in patients with prehypertension.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available